Diagnostic News and Research

RSS

John Muir Health earns Network Cancer Program accreditation

John Muir Health’s Walnut Creek and Concord campuses have earned a three-year accreditation with commendation as a Network Cancer Program (NCP) from the American College of Surgeons Commission on Cancer (CoC), a consortium of professional organizations dedicated to improving survival and quality of life for cancer patients. John Muir Health is one of only two hospitals in California and the only one in the San Francisco Bay Area to receive the recognition.

24 Oct 2009

Health Canada issues medical device license for IMRISNV and IMRIScardio systems

IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") today announced that Health Canada has issued a medical device licence for the Company's IMRX system permitting IMRIS to market its newest products, IMRISNV and IMRIScardio in Canada.

24 Oct 2009

Web-Based AXIS Image Management System released by Escalon Digital Solutions

Escalon Medical Corp. today announced that its Escalon Digital Solutions subsidiary released its Web-Based AXIS(TM) Image Management System.

24 Oct 2009

Seattle Genetics reports its third-quarter financial results

Seattle Genetics, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009. The company also highlighted recent product development progress.

24 Oct 2009

BD to acquire HandyLab

BD (Becton, Dickinson and Company)announced today that it signed a definitive agreement to acquire HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms. The acquisition is subject to regulatory approvals and is expected to close during the first quarter of fiscal year 2010. The financial terms of the agreement were not disclosed.

From BD (Becton, Dickinson and Company) 24 Oct 2009

Bio-Rad Laboratories to acquire diagnostic businesses of Biotest AG for 45 million euros

Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has signed an agreement to acquire certain diagnostic businesses of Biotest AG for 45 million euros.

24 Oct 2009

Physicians' recognize benefits of genetic testing; say formal education required to put it into practice

Medco Health Solutions, Inc.(NYSE: MHS) and the American Medical Association (AMA) today announced the findings of a national benchmark survey on physicians' acceptance, use and education regarding pharmacogenomic testing.

23 Oct 2009

Continucare acquires two additional centers

Continucare Corporation (NYSE Amex:CNU) announced today that it has expanded its sleep diagnostic division with the acquisition of two additional centers. Seredor Corporation, Continucare’s newly established subsidiary, has purchased the assets of Sleep Disorder Solutions, Inc., a full service operator of sleep diagnostic centers, with sleep diagnostic centers in South Miami and Pembroke Pines, Florida.

23 Oct 2009

ISHLT Infectious Disease Council issues new H1N1 advisory for cardiothoracic transplantation programs

Each year 3-5 million people have severe cases and 250-500,000 die from complications of seasonal influenza world-wide. This year, the novel 2009 H1N1 (nH1N1) influenza, previously called swine flu, has reached pandemic status.

23 Oct 2009

Practical guidance for cardiothoracic transplant programs in view of H1N1 flu pandemic

23 Oct 2009

Newcardio expert to present clinical validation data of Phase I and TQT studies on ECG

NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that Dr. Sam George, NewCardio's Senior Consultant, will join a distinguished roster of speakers, moderators and panelists at the Cardiac Safety Research Consortium (CSRC) annual meeting in Maryland at the Marriot Bethesda, Pooks Hill location on October 29-30, 2009.

23 Oct 2009

Vidacare to release results of validation study on its OnControl Bone Marrow System

Vidacare Corporation has completed an analysis and is releasing the results of a validation study on its OnControl™ Bone Marrow System, the first effort in decades to improve the safety, control, and comfort of bone marrow aspiration and biopsy procedures.

23 Oct 2009

Vasamed partners with BBHOP for peripheral arterial disease research

On Saturday, November 7, 2009 Vasamed Inc., provider of diagnostic technologies that detect peripheral arterial disease in patients with diabetes, will partner with the Black Barbershop Health Outreach Program (BBHOP) in its mission to help African Americans identify the connection between peripheral arterial disease (PAD), diabetes, obesity and hypertension through early detection and referral to appropriate medical resources.

23 Oct 2009

New Category I CPT code for AspirinWorks Test Kit

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, announced today that a new Category I Current Procedural Terminology (CPT) code has been published by the American Medical Association (AMA) for the AspirinWorks Test Kit.

23 Oct 2009

Aethlon Medical establishes ESI as a wholly owned subsidiary

Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced today that it has established Exosome Sciences, Inc. (ESI) as a wholly owned subsidiary of the Company.

23 Oct 2009

Early diagnostic for ovarian cancer to be developed

BioProspecting NB Inc. (BPNBI) and the Atlantic Cancer Research Institute (ACRI) have established a formal collaboration to develop an early diagnostic for ovarian cancer based on BPNBI's unique, proprietary cancer management platform.

23 Oct 2009

Ellex Medical Lasers to launch latest version of Eye Cubed diagnostic ultrasound system

Ellex Medical Lasers Limited, a global leader in the design and manufacture of ophthalmic laser and ultrasound systems, today announced that it will introduce the latest version of the Eye Cubed(TM) diagnostic ultrasound system at the annual meeting of the American Academy of Ophthalmology (AAO), October 24 - 27, 2009 in San Francisco.

23 Oct 2009

Acrongenomics participates in Molecular Vision's 2 million GBP funding round

Acrongenomics, Inc. are pleased to announce that they have continued their support to Molecular Vision, an emerging developer of quantitative point-of-care (POC) diagnostic devices, by participating in its 2 million GBP funding round. Imperial Innovations Group plc (AIM: IVO, 'Imperial Innovations'), a leading technology commercialisation and investment company, led the £2 million funding round by committing £1.5 million.

23 Oct 2009

ZyGEM and Phthisis Diagnostics to develop products for detecting infectious pathogens

ZyGEM Corp. Ltd. and Phthisis Diagnostics today announced that they have entered into an agreement to develop products enabling the detection of infectious pathogens in complex samples, such as stool, blood and water.

23 Oct 2009

NCI awards $2.8 million grant to Allegro Diagnostics

Allegro Diagnostics, a leader in the field of molecular diagnostics for lung cancer, has announced that its clinical study for BronchoGen(TM), a diagnostic test for patients suspected of having lung cancer, will receive up to $2.8 million in funding for a Phase I/II Fast Track Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI).

22 Oct 2009

Diagnostic News and Research

John Muir Health earns Network Cancer Program accreditation

Health Canada issues medical device license for IMRISNV and IMRIScardio systems

Web-Based AXIS Image Management System released by Escalon Digital Solutions

Seattle Genetics reports its third-quarter financial results

BD to acquire HandyLab

Bio-Rad Laboratories to acquire diagnostic businesses of Biotest AG for 45 million euros

Physicians' recognize benefits of genetic testing; say formal education required to put it into practice

Continucare acquires two additional centers

ISHLT Infectious Disease Council issues new H1N1 advisory for cardiothoracic transplantation programs

Practical guidance for cardiothoracic transplant programs in view of H1N1 flu pandemic

Newcardio expert to present clinical validation data of Phase I and TQT studies on ECG

Vidacare to release results of validation study on its OnControl Bone Marrow System

Vasamed partners with BBHOP for peripheral arterial disease research

New Category I CPT code for AspirinWorks Test Kit

Aethlon Medical establishes ESI as a wholly owned subsidiary

Early diagnostic for ovarian cancer to be developed

Ellex Medical Lasers to launch latest version of Eye Cubed diagnostic ultrasound system

Acrongenomics participates in Molecular Vision's 2 million GBP funding round

ZyGEM and Phthisis Diagnostics to develop products for detecting infectious pathogens

NCI awards $2.8 million grant to Allegro Diagnostics

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News